{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:43:19Z","timestamp":1793194999204,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019370","name":"The Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/50026\/2020"],"award-info":[{"award-number":["UIDB\/50026\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jpsychires.2025.12.007","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:51:14Z","timestamp":1765525874000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Mapping dopamine's role in obsessive-compulsive disorder: A scoping review of neural circuits, brain regions, and behavioral implications"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1003-5640","authenticated-orcid":false,"given":"Pedro","family":"Mota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pic\u00f3-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jpsychires.2025.12.007_bib1","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.euroneuro.2015.08.017","article-title":"Hyper-influence of the orbitofrontal cortex over the ventral striatum in obsessive-compulsive disorder","volume":"25","author":"Abe","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.12.007_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/HRP.0000000000000050","article-title":"Comorbidity between attention deficit\/hyperactivity disorder and obsessive-compulsive disorder across the lifespan: a systematic and critical review","volume":"23","author":"Abramovitch","year":"2015","journal-title":"Harv. Rev. Psychiatr."},{"issue":"9688","key":"10.1016\/j.jpsychires.2025.12.007_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(09)60240-3","article-title":"Obsessive-compulsive disorder","volume":"374","author":"Abramowitz","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.12.007_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41386-021-01130-2","article-title":"The prefrontal cortex and OCD","volume":"47","author":"Ahmari","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.12.007_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/psychoactives4010002","article-title":"A systematic review on the prevalence of comorbid substance use disorder in obsessive\u2013compulsive disorder among the general population","volume":"4","author":"Akosile","year":"2025","journal-title":"Psychoactives"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib6","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2147\/NDT.S62785","article-title":"Animal models of obsessive\u2013compulsive disorder: utility and limitations","author":"Alonso","year":"2015","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.12.007_bib7","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.41418","article-title":"The efficacy of aripiprazole versus risperidone as augmentation therapy in treatment-resistant obsessive-compulsive disorder: a double blind clinical trial","volume":"20","author":"Assarian","year":"2018","journal-title":"Iran. Red Crescent Med. J."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.12.007_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamapsychiatry.2013.173","article-title":"Abnormally high degree connectivity of the orbitofrontal cortex in obsessive-compulsive disorder","volume":"70","author":"Beucke","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.12.007_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157488907779561727","article-title":"Glutamatergic dysfunction-newer targets for anti-obsessional drugs","volume":"2","author":"Bhattacharyya","year":"2007","journal-title":"Recent Pat. CNS Drug Discov."},{"issue":"8","key":"10.1016\/j.jpsychires.2025.12.007_bib10","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/npp.2015.36","article-title":"An examination of rostral anterior cingulate cortex function and neurochemistry in obsessive\u2013compulsive disorder","volume":"40","author":"Brennan","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(25)00194-4","article-title":"Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK","author":"Browning","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.conb.2014.08.008","article-title":"Striatal circuits, habits, and implications for obsessive\u2013compulsive disorder","volume":"30","author":"Burguiere","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jpsychires.2025.12.007_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fpsyt.2019.00557","article-title":"Co-morbid obsessive\u2013compulsive disorder and attention deficit hyperactivity disorder: neurobiological commonalities and treatment implications","volume":"10","author":"Cabarkapa","year":"2019","journal-title":"Front. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.12.007_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41386-021-01207-y","article-title":"Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in rats","volume":"47","author":"Casado-Sainz","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib15","article-title":"Changes in volume of subregions within basal ganglia in obsessive\u2013compulsive disorder: a study with Atlas-based and VBM methods","volume":"16","author":"Chen","year":"2022","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.12.007_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4088\/JCP.v66n0107","article-title":"The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients","volume":"66","author":"Connor","year":"2005","journal-title":"J. Clin. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.12.007_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000325223","article-title":"Functional neuroimaging in obsessive-compulsive disorder","volume":"64","author":"Del Casale","year":"2011","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib18","unstructured":"Delgado, S.V., Treatment-Resistant OCD: There's More we can Do."},{"issue":"10","key":"10.1016\/j.jpsychires.2025.12.007_bib19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.biopsych.2004.01.023","article-title":"Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder","volume":"55","author":"Denys","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.649833","article-title":"Case report: treatment of a comorbid attention deficit hyperactivity disorder and obsessive\u2013compulsive disorder with psychostimulants","volume":"12","author":"Dogan-Sander","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.007_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.608520","article-title":"Dopaminergic system alteration in anxiety and compulsive disorders: a systematic review of neuroimaging studies","volume":"14","author":"Dong","year":"2020","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.12.007_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbr.2006.01.024","article-title":"Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder","volume":"169","author":"Dvorkin","year":"2006","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.12.007_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000522136","article-title":"Autoimmune obsessive-compulsive disorder with novel anti-basal ganglia antibodies","volume":"91","author":"Endres","year":"2022","journal-title":"Psychother. Psychosom."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.12.007_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41398-021-01700-4","article-title":"Immunological causes of obsessive-compulsive disorder: is it time for the concept of an \u201cautoimmune OCD\u201d subtype?","volume":"12","author":"Endres","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2025.12.007_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.biopsych.2013.06.021","article-title":"Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder","volume":"75","author":"Figee","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.12.007_bib26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.euroneuro.2015.12.003","article-title":"Compulsivity in obsessive\u2013compulsive disorder and addictions","volume":"26","author":"Figee","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.007_bib27","first-page":"27","article-title":"Obsessive-compulsive disorder: diagnosis and treatment","volume":"60","author":"Goodman","year":"1999","journal-title":"J. Clin. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.12.007_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1176\/appi.ajp.2020.20111601","article-title":"Harmonizing the neurobiology and treatment of obsessive-compulsive disorder","volume":"178","author":"Goodman","year":"2021","journal-title":"Am. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.12.007_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/YIC.0000000000000368","article-title":"Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial","volume":"36","author":"Grant","year":"2021","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.jpsychires.2025.12.007_bib30","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1017\/S0033291716003305","article-title":"Increased fronto-striatal reward prediction errors moderate decision making in obsessive\u2013compulsive disorder","volume":"47","author":"Hauser","year":"2017","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.12.007_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pscychresns.2005.07.002","article-title":"Serotonin and dopamine transporter imaging in patients with obsessive\u2013compulsive disorder","volume":"140","author":"Hesse","year":"2005","journal-title":"Psychiatr. Res. Neuroimaging"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib32","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00213-019-05325-w","article-title":"Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2\/3 receptor agents","volume":"236","author":"Kanen","year":"2019","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.12.007_bib33","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19ac13182","article-title":"Pharmacotherapy for treatment-resistant obsessive-compulsive disorder","volume":"81","author":"Kayser","year":"2020","journal-title":"J. Clin. Psychiatr."},{"issue":"3\u20134","key":"10.1016\/j.jpsychires.2025.12.007_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000106474","article-title":"Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I] IPT SPECT before and after treatment with serotonin reuptake inhibitors","volume":"55","author":"Kim","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40268-018-0246-8","article-title":"Critical review of the use of second-generation antipsychotics in obsessive\u2013compulsive and related disorders","volume":"18","author":"Kim","year":"2018","journal-title":"Drugs R&D"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.12.007_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1073858411401413","article-title":"Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging","volume":"18","author":"Ko","year":"2012","journal-title":"Neuroscientist"},{"issue":"7","key":"10.1016\/j.jpsychires.2025.12.007_bib37","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4088\/JCP.v61n0709","article-title":"Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder","volume":"61","author":"Koran","year":"2000","journal-title":"J. Clin. Psychiatr."},{"issue":"11","key":"10.1016\/j.jpsychires.2025.12.007_bib38","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.4088\/JCP.08m04605","article-title":"Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder","volume":"70","author":"Koran","year":"2009","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.007_bib39","series-title":"Obsessive-Compulsive Disorder and Tourette's Syndrome","first-page":"125","article-title":"Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions: a neuropsychological, magnetic resonance imaging and positron tomography study","author":"Laplane","year":"2022"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib40","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.2147\/IJGM.S318069","article-title":"Continuous theta-burst stimulation over the right orbitofrontal cortex in treatment-resistant obsessive-compulsive disorder treatment: a randomized sham-controlled trial","author":"Liu","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.12.007_bib41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/cne.24948","article-title":"Altered spontaneous activity and effective connectivity of the anterior cingulate cortex in obsessive\u2013compulsive disorder","volume":"529","author":"Long","year":"2021","journal-title":"J. Comp. Neurol."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.12.007_bib42","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/cercor\/bhaa397","article-title":"Nucleus accumbens stimulation modulates inhibitory control by right prefrontal cortex activation in obsessive-compulsive disorder","volume":"31","author":"Lopez-Sosa","year":"2021","journal-title":"Cerebr. Cortex"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.12.007_bib43","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1017\/S0954579408000606","article-title":"The neural bases of obsessive\u2013compulsive disorder in children and adults","volume":"20","author":"Maia","year":"2008","journal-title":"Dev. Psychopathol."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.12.007_bib44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2014.13121700","article-title":"Reward-based spatial learning in unmedicated adults with obsessive-compulsive disorder","volume":"172","author":"Marsh","year":"2015","journal-title":"Am. J. Psychiatr."},{"issue":"Suppl. 2","key":"10.1016\/j.jpsychires.2025.12.007_bib45","first-page":"396","article-title":"Brexpiprazole augmentation in treatment resistant OCD: safety and efficacy in an Italian sample","volume":"36","author":"Martiadis","year":"2024","journal-title":"Psychiatr. Danub."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.12.007_bib46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3171\/2016.1.JNS15601","article-title":"Role of the dorsal anterior cingulate cortex in obsessive-compulsive disorder: converging evidence from cognitive neuroscience and psychiatric neurosurgery","volume":"126","author":"McGovern","year":"2017","journal-title":"J. Neurosurg."},{"issue":"12","key":"10.1016\/j.jpsychires.2025.12.007_bib47","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1177\/1087054716669226","article-title":"The clinical characteristics of ADHD and obsessive-compulsive disorder comorbidity","volume":"24","author":"Mersin Kilic","year":"2020","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.jpsychires.2025.12.007_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-981-10-4358-1_11","article-title":"Treatment resistance in obsessive-compulsive disorder","author":"Middleton","year":"2019","journal-title":"Treatment Resist. Psychiatr.: Risk Factors Biol. Manag."},{"key":"10.1016\/j.jpsychires.2025.12.007_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00213-010-1963-z","article-title":"Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation","volume":"212","author":"Morein-Zamir","year":"2010","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.jpsychires.2025.12.007_bib50","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.euroneuro.2015.07.003","article-title":"Stress induced risk-aversion is reverted by D2\/D3 agonist in the rat","volume":"25","author":"Morgado","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1615","key":"10.1016\/j.jpsychires.2025.12.007_bib51","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0435","article-title":"Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive\u2013compulsive disorder as an example of overlapping clinical and genetic heterogeneity","volume":"368","author":"Murphy","year":"2013","journal-title":"Phil. Trans. Biol. Sci."},{"key":"10.1016\/j.jpsychires.2025.12.007_bib52","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00213-019-05292-2","article-title":"Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder","volume":"236","author":"Murray","year":"2019","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.12.007_bib53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pscychresns.2010.04.004","article-title":"Dopamine D1 receptor binding in the anterior cingulate cortex of patients with obsessive\u2013compulsive disorder","volume":"183","author":"Olver","year":"2010","journal-title":"Psychiatr. Res. Neuroimaging"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib54","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br. Med. J."},{"issue":"7","key":"10.1016\/j.jpsychires.2025.12.007_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219578","article-title":"Electrophysiological and imaging evidence of sustained inhibition in limbic and frontal networks following deep brain stimulation for treatment refractory obsessive compulsive disorder","volume":"14","author":"Park","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.12.007_bib56","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder","volume":"42","author":"Perani","year":"2008","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.12.007_bib57","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.euroneuro.2005.01.003","article-title":"SERT and DAT availabilities under citalopram treatment in obsessive\u2013compulsive disorder (OCD)","volume":"15","author":"Pogarell","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2025.12.007_bib58","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.4103\/0019-5545.196976","article-title":"Clinical practice guidelines for obsessive-compulsive disorder","volume":"59","author":"Reddy","year":"2017","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00044011-200828070-00005","article-title":"Quetiapine and ziprasidone as adjuncts in treatment-resistant obsessive-compulsive disorder: a retrospective comparative study","volume":"28","author":"Savas","year":"2008","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.jpsychires.2025.12.007_bib60","first-page":"159","article-title":"Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder","author":"Saxena","year":"2022","journal-title":"Obsess. Compul. Disorder Tourette's Syndr."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.12.007_bib61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/archpsyc.1996.01830020023004","article-title":"Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder","volume":"53","author":"Schwartz","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2025.12.007_bib62","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1017\/S146114571200154X","article-title":"Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity","volume":"16","author":"Sesia","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.12.007_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.703701","article-title":"Comorbidities in obsessive-compulsive disorder across the lifespan: a systematic review and meta-analysis","volume":"12","author":"Sharma","year":"2021","journal-title":"Front. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.12.007_bib64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","article-title":"Obsessive\u2013compulsive disorder","volume":"5","author":"Stein","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jpsychires.2025.12.007_bib65","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jad.2024.07.123","article-title":"Abnormalities in static and dynamic intrinsic neural activity and neurotransmitters in first-episode OCD","volume":"363","author":"Tao","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.12.007_bib66","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3390\/life13041043","article-title":"Pramipexole augmentation for treatment-resistant Unipolar and bipolar depression in the real world: a systematic review and meta-analysis","volume":"13","author":"Tundo","year":"2023","journal-title":"Life"},{"issue":"12","key":"10.1016\/j.jpsychires.2025.12.007_bib67","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1176\/appi.ajp.161.12.2201","article-title":"Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I] \u03b2-CIT SPECT","volume":"161","author":"Van Der Wee","year":"2004","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.12.007_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-020-02913-5","article-title":"Multi-level assessment of obsessive-compulsive disorder (OCD) reveals relations between neural and neurochemical levels","volume":"20","author":"Viol","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"S3","key":"10.1016\/j.jpsychires.2025.12.007_bib69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1017\/S1092852900002479","article-title":"Neurobiology of obsessive-compulsive disorder: serotonin and beyond","volume":"12","author":"Westenberg","year":"2007","journal-title":"CNS Spectr."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625007538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625007538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T20:00:38Z","timestamp":1780862438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395625007538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":69,"alternative-id":["S0022395625007538"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.12.007","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping dopamine's role in obsessive-compulsive disorder: A scoping review of neural circuits, brain regions, and behavioral implications","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}